INFORMED CONSENT FOR GENETIC RESEARCH ON STORED TISSUE SAMPLES

被引:203
作者
CLAYTON, EW
STEINBERG, KK
KHOURY, MJ
THOMSON, E
ANDREWS, L
KAHN, MJE
KOPELMAN, LM
WEISS, JO
机构
[1] VANDERBILT UNIV, DEPT PEDIAT, NASHVILLE, TN USA
[2] VANDERBILT UNIV, SCH LAW, NASHVILLE, TN 37240 USA
[3] CTR DIS CONTROL & PREVENT, BIRTH DEFECTS & GENET DIS BRANCH, MOLEC BIOL BRANCH, ATLANTA, GA 30341 USA
[4] NATL CTR HUMAN GENOME RES, BETHESDA, MD USA
[5] CHICAGO KENT COLL LAW, CHICAGO, IL USA
[6] NATL BREAST CANC COALIT, WASHINGTON, DC USA
[7] VIRGINIA BREAST CANC FDN, RICHMOND, VA USA
[8] E CAROLINA UNIV, SCH MED, DEPT MED HUMANITIES, GREENVILLE, NC USA
[9] ALLIANCE GENET SUPPORT GRP, CHEVY CHASE, MD USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1995年 / 274卷 / 22期
关键词
D O I
10.1001/jama.274.22.1786
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective.-To develop recommendations for obtaining adequate informed consent in the future when gathering tissue samples that may be used for genetic studies and defining the circumstances under which it is necessary to obtain further consent if tissue samples already in hand are to be used for such research. Participants.-Scientists, ethicists, lawyers, and consumers selected by the National Center for Human Genome Research and the Centers for Disease Control and Prevention to represent a wide array of opinions. Evidence.-Statutes, regulations, and cases and articles on law and ethics. Consensus Process.-Initial workshop, followed by circulation of several drafts of this document with opportunities for comment by workshop participants and others as well as smaller meetings involving participants with widely differing views. Conclusions.-Genetic research using stored tissue samples poses an array of benefits and risks to individuals, researchers, and society, As a result, the workshop participants conclude that (1) informed consent is required for all genetic research using linkable samples unless conditions for limitation or waiver are met; (2) informed consent is not required for genetic research using anonymous samples but may be considered if identifiers are to be removed from currently linkable samples; (3) institutional review boards could usefully review all protocols that propose to use samples for genetic research; and (4) further work regarding these issues is warranted.
引用
收藏
页码:1786 / 1792
页数:7
相关论文
共 19 条
  • [1] ANDREWS LB, 1987, MED GENETICS LEGAL F
  • [2] ANDREWS LB, 1986, HASTINGS CTR REP OCT, P28
  • [3] ANNAS GJ, 1995, GENETIC PRIVACY ACT
  • [4] CAPRON AM, 1991, J CLIN EPIDEMIOL, V44, pS81
  • [5] Clayton Ellen Wright, 1992, Houst Law Rev, V29, P85
  • [6] REMOVING THE SHADOW OF THE LAW FROM THE DEBATE ABOUT GENETIC TESTING OF CHILDREN
    CLAYTON, EW
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 57 (04): : 630 - 634
  • [7] EARLEY CL, 1995, AM J HUM GENET, V57, P727
  • [8] FEINLEIB M, 1991, J CLIN EPIDEMIOL, V44, pS73
  • [9] HARPER PS, 1994, GENETIC COUNSELING P, P84
  • [10] KOHRMAN A, 1995, PEDIATRICS, V95, P314